- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
精品资料
精品资料
PAGE / NUMPAGES
精品资料
【 H 】 G C L 5 - 1
指导原则编号:
化学药品、生物制品说明书指导原则
(第二稿)
二 00 四年三月一日
1
目
录
一.概述 ························ 4
二.药品说明书形式与内容的一般要求 ··········· 4
三.说明书形式与内容的具体要求 ············· 8
(一)标题························································································8
(二)警示语····················································································8
(三)药品名称·················································································8
(四)成份························································································9
(五)性状························································································9
(六)处方组成·················································································9
(七)药理毒理·················································································9
(八)药代动力学···········································································10
(九)临床研究···············································································11
(十)适应证··················································································11
(十一)用法用量···········································································12
(十二)不良反应···········································································13
(十三)禁忌··················································································14
(十四)警告··················································································15
(十五)注意事项···········································································16
(十六)妊娠期妇女及哺乳期妇女用药·······································17
(十七)儿童用药···········································································19
(十八)老年患者用药···································································20
2
(十九)药物相互作用······························
您可能关注的文档
- E-厄贝沙坦氢氯噻嗪片 华海药业 一致性评价研究报告.doc
- E-厄贝沙坦氢氯噻嗪片 华海药业 说明书.doc
- E-厄贝沙坦氢氯噻嗪片 正大天晴 一致性评价研究报告.doc
- E-厄贝沙坦氢氯噻嗪片 正大天晴 说明书.doc
- E-厄贝沙坦片 华海药业 说明书.doc
- E-厄贝沙坦片 恒瑞医药 说明书.doc
- E-厄贝沙坦片 恒瑞医药 一致性评价研究报告.doc
- E-厄贝沙坦片 海正辉瑞制药 一致性评价研究报告.doc
- E-厄贝沙坦片 海正辉瑞制药 说明书.doc
- E-恩曲利替片 审评报告.doc
- H-化学药品注射剂与塑料包装材料相容性研究技术指导原则(试行)20120907.doc
- H-化学药品注射剂基本技术要求(试行) 20100510.doc
- H-化学药品注射剂与药用玻璃包装容器相容性研究技术指导原则(试行)20150728.docx
- H-化学药物临床药代动力学研究技术指导原则 20070823.doc
- H-化学药品补充申请研究技术指导原则 20070813.doc
- H-化学药物一般药理学研究技术指导原则 20070823.doc
- H-化学药物制剂研究技术指导原则 20070823.doc
- H-化学药物临床试验报告的结构与内容技术指导原则 20070823.doc
- H-化学药物制剂人体生物利用度和生物等效性研究技术指导原则 20070823.doc
- H-化学药物口服缓释制剂药学研究技术指导原则 20071121.doc
最近下载
- 福建省突发化学中毒卫生应急预案.doc VIP
- (最新)执业兽医师聘用协议合同书5篇.docx
- 盘扣式落地式卸料平台专项施工方案新版.docx VIP
- 2025年中国私募股权基金行业市场运行现状及投资战略研究报告.docx
- 护理礼仪与人际沟通.pptx VIP
- 二次函数复习课公开课二次函数复习课公开课.ppt VIP
- 电力工程项目建设用地指标(风电场)(建标〔2011〕209号).pdf VIP
- DB3301_T0329.1—2020_社会救助家庭家境调查规范第1部分:工作程序_杭州市 .docx VIP
- 建筑工程师工作总结范文.pptx
- 2025年中考语文二轮总复习:说明文阅读(附答案解析).doc
文档评论(0)